Direct agonists activate receptors and influence ion channels directly.
Receptor blockers prevent normal ligand binding, negatively affecting synaptic transmission.
Key Terms in Neurotransmission
Agonist: Enhances neurotransmitter effects on postsynaptic cells.
Antagonist: Inhibits neurotransmitter effects on postsynaptic cells.
Direct Agonist: Activates the receptor directly.
Receptor Blocker: Occupies binding site without activating the receptor.
Indirect Agonist/Antagonist: Acts on different binding sites and modifies receptor action without blocking the primary binding site.
Neurotransmitter Reuptake and Destruction
Termination of Effects: Occurs via reuptake or enzymatic destruction of neurotransmitter.
Role of Drugs: Can block either reuptake (by binding with transporter molecules) or inhibit enzymatic destruction (e.g., inhibitors of acetylcholinesterase).
Outcome: Prolonged neurotransmitter presence in synaptic cleft, enhancing postsynaptic effects (acting as agonists).
Drug Action Sites
Processes Interfered with by Drugs:
Synthesis of neurotransmitters.
Storage in vesicles.
Release mechanisms.
Receptor interactions (both presynaptic and postsynaptic).
Reuptake processes.
Enzymatic destruction.
Agonist vs Antagonist Action: Affects various neurotransmitter pathways differently.
Types of Neurotransmitters
Major Neurotransmitters:
Acetylcholine (ACh): Involved in muscular movement, CNS functions, REM sleep; has ionotropic (nicotinic) and metabotropic (muscarinic) receptors.
Monoamines: Include dopamine, norepinephrine, serotonin, have similarities in molecular structures.
Dopamine: Key role in movement, attention; implicated in addiction pathways.
Major Pathways:
Mesolimbic Pathway: Reward and pleasure.
Mesocortical Pathway: Cognition and decision-making.
Nigrostriatal Pathway: Motor control (linked to Parkinson's disease).
Understanding neurotransmitter action and drug effects is crucial in physiological psychology, highlighting the complex interactions that underlie brain function and influence behavior.